SCHEMBL17023

SCHEMBL17023

CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2CNCCc2ccccc2)cc1)C(F)(F)F

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 12/20 0.66
GCK P35557 8/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16826 0.92 GCKR (0.68) GCKRGCK
SCHEMBL17952 0.90 GCK (0.69) GCKRGCK
SCHEMBL17778 0.89 GCKR (0.64) GCKRGCK
SCHEMBL12077796 0.88 GCKR (0.75) GCKRGCK
SCHEMBL16547 0.88 GCKR (0.85) GCKRGCK
SCHEMBL16095 0.88 GCKR (0.85) GCKRGCK
SCHEMBL16293 0.88 GCKR (0.85) GCKRGCK
SCHEMBL17027 0.87 GCK (0.69) GCKRGCK
SCHEMBL12078618 0.87 GCK (0.69) GCKRGCK
SCHEMBL19516 0.87 GCK (0.69) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed